Madhav V. Dhodapkar MBBS

Arthur H. Bunker and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Chief, Section of Hematology, Department of Internal Medicine; Clinical Research Program Leader, Hematology Program, Yale Cancer Center

Departments & Organizations

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Immunology | Molecular Medicine, Pharmacology, and Physiology

Yale Medical Group

Cancer Center, Yale: Hematology Program | Cancer Immunology | Dhodapkar Lab

Immunobiology: HTI


National Gaucher Disease Treatment Center


Medical School: All India Instt. of Medical Sciences, New Delhi, India
Fellowship (Hematology / Oncology): Mayo Clinic, Rochester, MN

Prior Faculty appointments: Myeloma Institute, Little Rock, AR; Memorial Sloan Kettering Cancer Center, New York, NY; The Rockefeller University, New York, NY

Research Interests: Immunobiology of myeloma; Development of novel biological approaches to treat cancer; dendritic cell biology


  • M.B.B.S., All India Institute of Medical Sciences, New Delhi , 1987

Selected Publication

  • Dhodapkar K, Banerjee D, Connolly J, Kukreja A, Matayeva E, Veri MC, Ravetch JV, Steinman RM, Dhodapkar MV. Selective blockade of the inhibitory FC-receptor (Fc-RIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med. 2007, 204: 1359-1369.